Home Newsfeeds Citigroup Maintains Sell on Palantir Technologies, Lowers Price Target to $5

Citigroup Maintains Sell on Palantir Technologies, Lowers Price Target to $5

Citigroup analyst Tyler Radke maintains Palantir Technologies (NYSE:PLTR) with a Sell and lowers the price target from $6 to $5.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Citigroup analyst Tyler Radke maintains Palantir Technologies (NYSE:PLTR) with a Sell and lowers the price target from $6 to $5.

Nasdaq Stock Trading Low Following Adenza Deal – A Golden Opportunity For Investors, Says Analyst

By Nabaparna Bhattacharya

June 13, 2:31 PM

Oppenheimer analyst Owen Lau reiterated an Outperform rating on the shares of Nasdaq, Inc. (NASDAQ: NDAQ), with a

NDAQ

News

Cigna Introduces Comprehensive, Cost-Effective Affordable Care Act Marketplace Plans In South Carolina

By Benzinga Newsdesk

October 19, 8:05 AM

Residents in four South Carolina counties will have Cigna health plan options on the individual marketplace for the 2023 Open Enrollment Period Plan features include virtual primary care through MDLIVE, $0 benefit

News

Fed Minutes: Several Participants Underlined The Need To Maintain A Restrictive Stance For As Long As Necessary; Several Participants Said As Policy Moved Into Restrictive Territory Risks Would Become More Two-Sided

By Benzinga Newsdesk

October 12, 2:13 PM

- Reuters

SPY

Raymond James Maintains Strong Buy on Huntington Bancshares, Raises Price Target to $17

By Benzinga Newsdesk

July 22, 7:54 AM

Raymond James analyst David Long maintains Huntington Bancshares (NASDAQ:HBAN) with a Strong Buy and raises the price target from $16 to $17.

HBAN

Citigroup Maintains Sell on Palantir Technologies, Lowers Price Target to $5

Related Posts

Nasdaq Stock Trading Low Following Adenza Deal – A Golden Opportunity For Investors, Says Analyst

Cigna Introduces Comprehensive, Cost-Effective Affordable Care Act Marketplace Plans In South Carolina

Fed Minutes: Several Participants Underlined The Need To Maintain A Restrictive Stance For As Long As Necessary; Several Participants Said As Policy Moved Into Restrictive Territory Risks Would Become More Two-Sided

Raymond James Maintains Strong Buy on Huntington Bancshares, Raises Price Target to $17